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Summary: A Workshop Conference on UDP-glucuronyltransferase was held in order to bring together different inves-
tigators specialising in a particular aspect of the enzyme. The intention was to find a basis for a closer cooperation
between the different groups and to exchange ideas and methods making it possible to cross the hurdles facing those
who work in the field of glucuronidation of endogenous and exogenous substances.
The topics which were chosen for the meeting covered the following aspects: methods of determination of UDP-
glucuronyltransferase activity; problems relating to the origin of the enzyme and the nature of the substrate; applica-
tion of assays of UDP-glucuronyltransferase in clinical chemistry; enzyme-substrate interactions and factors influencing
the enzymic reaction; the role of UDP^glucuronyltransferase in the entero-hepatic circulation of glucuronides, regula-
tion and induction of UDP-glucuronyltransferase, with a subsection on solubilisation and purification.
UDP-Glucuronyltransferase
Bericht über die Kleinkonferenz der Deutschen Gesellschaft für Klinische Chemie am 27. und 28. September 1977
in Schloß Auel
Zusammenfassung: Eine Kleinkonferenz über UDP-Glucuronyltransferase wurde veranstaltet, um Wissenschaftler, die
sich auf einen Teiläspekt des Enzyms spezialisiert haben, zu versammeln. Ziel war, eine Grundlage für eine engere
Zusammenarbeit zwischen den verschiedenen Gruppen zu finden sowie Ideen und Methoden auszutauschen, um Hür-
den, die auf dem Gebiet der Glueuronidierung von endp- und exogenen Substanzen arbeitenden Wissenschaftlern ent-
gegenstehen, zu überwinden.
Als Schwerpunkte des Treffens wurden folgende Aspekte ausgewählt: Methoden der Aktivitätsbestimmung von UDP-
Glucüronyltransferase; Probleme bezüglich Herkunft des Enzyms und der Natur des Substrats; Verwendung der Be-
stimmung von UPP-Glucurönyltrarisferase in der klinischen Chemie; Enzym-Substrat-Wechselwirkungen und die
enzymatische Reaktion beeinflussende Faktoren; die Rolle der UDP-Glucuronyltransferase im entero-hepatischen
Kreislauf von Glucurpniden; Regulation und Induktion von UDP-Glucuronyltransferase; Solubilisierung und Reini-
gung,
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K. P. M. Heirweg (Leuven, Belgium) discussed the need
for a reliable assay of bilirubin glucuronyltransferase.
The conjugation of bilirubin-IX in normal mammals in
vivo shows considerable complexity: in addition to the
attachment of bilirubin-IX (B) to one of several sugar
moieties (xylose, glucose, glucuronic acid), mono- and
di-conjugates can also be formed (homogenous and
mixed conjugates). The presence of a variety of addi-
tional hexuronic acid-containing conjugates in body
fluids of patients with cholestasis can be explained with-
out invoking conjugating processes other than those
observed for normal animals. Owing to the complexity
of the conjugates and, in addition, to some rather bizarre
chemical properties of bilirubin-IX (B) and its conjugates
(in particular, the monoconjugates), progress in devel-
oping adequate assays for bilirubin glucuronyltrans-
ferase has been slow.
Specific difficulties are related to the following points:
1. The acceptor substrate, bilirubin-IX (B) and/or the
product(s), may undergo changes during enzymic incuba-
tion (destructive processes and isomerisation by di-
pyrrole exchange).
2. So far, determination of product(s) has been based
essentially on sampling procedures. Either transformation
of conjugated tetrapyrroles into dipyrrolic azo-deriva-
tives, or extraction of the tetrapyrroles followed by
some separation method, have been used as the first
step in quantitating the conjugated product(s). Both
approaches present specific pitfalls, leading to arte-
factual changes which confuse the final interpretation
of results.
3. Depending on the type of assay adopted, the final
results may represent (a) an ill-defined fraction of
conjugated B, (b) 'sugar transfer rates', or (c) 'bilirubin
conjugation rates'.
4. Some assays allow one to estimate the ratio of mono-
and di-conjugates formed, other assays do not.
A number of procedures can be adopted for presenting
the acceptor substrate, B, to the enzyme, e.g. addition of
a bilirubinate solution to a microsomal preparation, or
previous solution of B in some organic solvent, or
binding of B to some binding protein or other binding
vehicle. Similar techniques have been employed in
assays of glucuronyltransferase and other enzymes with
various hydrophobic substrates. Major problems
affecting the interpretation of the kinetic results are:
1. Which fraction of the substrate has to be used in the
kinetic formulation of the enzymic reaction (factors
such as protein-binding, effects on membranes of the
added protein, distribution of substrate between incuba-
tion medium and membrane material, dimerisation or
oligomerisation equilibria)?
2. Do any of the procedures for presenting acceptor
substrate modify the properties of the enzymes assayed,
e. g. by changing the properties of the surrounding lipid
matrix?
3. What can be the impact of such factors when more
complex systems are studied (e. g. influence of inhibitors
or activators)? A moderate excess of albumin in reaction
mixtures protects bilirubin against the above mentioned
transformations. Bilirubin, in the absence of albumin,
precipitates onto the micrpsomal membranes, resulting
probably in alteration of the properties of the mem-
branes. Albumin prevents the changes by protecting the
membranes from dissolution. The methods for the deter-
mination of bilirubin in serum, routinely employed in
clinical laboratories, may be considered as reliable; the
methods used to quantitate directly reacting bilirubin
do not measure all the conjugates, e. g. conjugates of
other sugars.
Clofibrate lowers serum bilirubin levels in patients with
Gilbert's syndrome and enhances the bilirubin glucuronyl-
transferase activity as well as the Z-protein content in the
rat liver. The investigations of K. Kutz (Bonn, F. R.
Germany) revealed that treatment of rats with clofibrate,
100 mg/kg body weight daily intraperitoneally for two
weeks, increased the activity of bilirubin glucuronyl-
transferase. This increase was similar to that observed
by treatment of animals with 90 ng phenobarbital per
kg body weight. It appears that clofibrate enhances the
excretion rate of bilirubin into the bile. The bile of
treated animals contained considerable amounts of
bilirubin diconjugates. It was speculated that diconjuga-
tion takes place at the canalicular membrane. Whether
the bilirubin lowering effect in patients with Gilbert*$
syndrome is due to the induction of bilirubin glucuronyl-
transferase remains to be explored.
J. Fevery (Leuven, Belgium) discussed how far the
relative amounts of different bilirubin conjugates
excreted in bile reflect the UDP-glucuronyltransferase
activities measured in liver tissue. In a first approach,
11 animal species were examined. Only man, dog, cat
and rat excreted diconjugated bilirubins and only liver
tissue of the same four species formed diconjugates ·
upon incubation in vitro with UDP-sugars. In contrast,
the other animals excreted predominantly mono-
conjugates; incubation of liver tissue of these animals
produced only monoconjugates. Furthermore, the
ratio, bilirubin glucoside to glucuronide, present in bile
also showed a correlation to the ratio of the transferase
activities obtained in liver. A further correlation be-
tween the in vitro measured glucuronyltransferase
activities and reported maximal rates of biliary excre-
tion in different animals also suggest a close link be-
tween enzyme activities and biliary output. In a second
study performed in rriän, it was found that the bilirubin
UDP-glucuronyltransferase deficiency, as demonstrated
in Gilbert's syndrome, Crigler-Najjar9 s disease and in
neonatal hyperbilirubinemia, is expressed in bile by a
decreased output of bilirubin diglucuronide. In the
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most severe deficiencies (Crigler-Najfar's disease),
increased amounts of unconjugated bilirubin-IX (a)
were even present in the bile. It seems, therefore, that
the in vitro measured transferase activities are a good
reflection of the in vivo situation. However, in biopsy
specimens from human cirrhotic liver widely scattered
UDP-glucuronyltransferase activities, ranging from low
to normal values, were found.
The solubility of various acceptor substrates in lipids is
an important factor in the rate of formation of the
glucuronic acid conjugate (H. Paul, A. Illing). Membrane
perturbants, such as sonication, addition of detergent or
alkane, or incubation with phospholipase or trypsin,
result initially in increased UDP-glucuronyltransferase
activity, frequently followed by deactivation. The parti-
tion coefficient between octanol and a buffer solution
has frequently been used for investigating the solubility
of chemicals in lipids. The relationship employed to
compare the partition coefficient (or lipid solubility)
of a compound with a biological response is the Mansch
analysis which uses the equation
log (relative biological response)
= log (partition coefficient) + constant.
This relationship has been found to hold for:
1. Unactivated enzyme activity (i. e. perturbation of
membranes) in rat liver homogenates using carboxylic,
thiolic and alcoholic acceptor substrates; aminophenöls
and aminobenzoates are included because they possess
two conjugatable groups.
2. 'Activation factor* for treatment of rat liver homo-
genate with Triton X-100, using different carboxylic,
thiolic and alcoholic acceptor substrates.
3. Enzyme activity in Triton X-100 activated rat liver
microsomes for a series of substituted phenol acceptor
substrates.
The activity of UDP-glucuronyltransferase in vivo
presumably lies within the endopläsmic reticulum mem-
brane. A lipid-jmpermeable barrier needs to be pene*
trated to allow access to the enzyme, which can be
achieved by membrane perturbants.
For the selection of standard assay conditions for
UDP-glucuronyltransferase, the ions required by the
native, membrane bound and the partially purified
enzyme must be present. Because of the accumulation
of lipophilic aglycons in the membrane, the estimation
of Km values may be complicated.
A new, simple and sensitive method for evaluation of
3-hydroxybenz(a)pyrene glucuromdation was described
by A. M. Batt (Nancy, France). It is based on the diminu-
tion of the amount of 3-hydroxybenz(a)pyrene after
incubating it with UDP-glucuronic acid and rat liver
microsomes. The fluorescence of 3-iiydroxy(a)pyrene
after addition of NaOH is measured for quantisation of
the rate of glucurpnidatipn. This method is less expensive
than a radiochemical method and suitable for routine
use. The sensitivity of the assay was 0.1 nmol/mg
protein per min; the Km for the acceptor substrate was
0.09 mmol/1 and 4.6 mmol/1 for UDP-glucuronic acid.
These values were obtained by untreated microsomes.
Substitution of UDP-glucuronic acid by UDP-glucose
does not lead to a conjugated product. Treatment of
liver microsomes with cholic acid or Triton X-100 or
digitonin inhibited glucuronidation of 3-hydroxy-
benz(a)-pyrene. Phospholipases A and C also were
inhibitory. Trypsin, however, was almost without an
effect. Administration of 3-methyl-cholanthrene,
20 mg/kg body weight on four consecutive days to rats
(Wistar), enhanced hepatic UDP-glucuronyltransferase
activity two to fivefold. Homozygous and heterozygous
Gunn rats possessed 40 and 50% activity, when
compared to the Wistar strain. Guinea pig liver micro-
somes had 2.5 fold higher activity than rat liver micro-
somes.
B. Burchell (Dundee, Scotland) was successful in puri-
fying rat hepatic microsomal UDP-glucuronyltransferase
to apparent homogeneity. Purification procedures in-
cluded solubilisation with detergent (Lubrol 12 A9),
precipitation with ammonium sulfate, DEAE, CM
cellulose chromatography and DEAE-Sephadex column
chromatography and finally the use of UDP-hexanol-
amine-agarose as affinity material. A 900-fold purifica-
tion over the 10000# supernatant was obtained, with
a yield of 1.75%. The yield of pure protein can be
increased significantly if the animals are pretreated with
phenobarbital. No large differences in the properties of
the enzyme between treated and non-treated animals
were detectable. The pure enzyme formed 4.6 nmol
4-nitrophenol glucuronide/min · mg protein. Only one
polypeptide band with a molecular weight of 57000
daltons was visible after SDS-gel electrophoresis. The
pure enzyme generally behaved as an 'activated' form
of the transferase. It was resistant to the action of
phospholipase C, but this would still be consistent with
phospholipid dependency if some phospholipids were
tightly bound and not-accessible to the phospholipase.
It was pointed out in the discussion that isolation of a
catalytically active protein, demonstrably free of phos-
pholipid-dependence, might be difficult. The protein
could be stabilised not only by products of phospho-
lipase action but also by traces of detergent used during
solubilisation. An antibody has been prepared with
which several questions of heterogeneity could be
answered. The pure enzyme contained activities toward
2-arriinophenol and 1-naphthol. The amino acid com-
position was not unusual.
P. Czygan (Heidelberg, Germany) reported that bile
acid glucuronides are present in serum, bile and urine
of patients with intra- and extrahepatic cholestasis. This
finding was checked by measuring bile and UDP-glu-
curonyltransferase activity in the isolated perfused rat
liver, in rat liver microsomes and in solubilised agarose-
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bound enzyme preparations. Glucuronidation occurred
with lithocholic, deoxycholic and chenodeoxycholic
acid, but not with their taurine or glycine conjugates.
The products are ester glucuronides, conjugated at the
—COOH group of the aglycone, and not the C-3 position
as originally supposed. Microsomal bile acid UDP-
glucuronyltransferase was activated by Triton X-100.
The enzyme could be induced by treatment of the rats
with phenobarbital but not with 3-methylcholanthrene.
Increased synthesis and excretion of bile acid glucuroni-
des was observed after phenobarbital treatment of
children with intrahepatic cholestasis. The glucuronic
acid conjugates of bile acids are only found in urine
during cholestasis, when high intracellular levels of the
aglycons are present. Their formation and excretion
may help to defend intracellular membranes against
the lytic action of excess bile acids, thus serving as an
important detoxifying mechanism.
/ Magdalou (Nancy, France) studied the influence of
dietary proteins on rat liver microsomal UDP-glucuronyl-
transferase withp-nitrophenol as acceptor substrate.
Wistar male rats were fed with a variety of protein diets:
soya, different kinds of yeast, and casein, given in a
proportion of 18% for continuous feeding. At the same
time, other rats were fed a depleted (no protein) diet
followed by repletion (18% protein). Among the
different liver enzymes studied (transaminases, ornithyl-
carbamyltransferase), UDP-glucuronyltransferase was
noticed to be very sensitive to a change in protein source.
With casein taken as the standard, soya protein was
found to cause an increase in enzyme activity and a
decrease in rat liver growth. The yeast (candida
tropicalis,Kluyveormycesfragilis), although ensuring
normal growth, increased the activity of UDP-glucuronyl-
transferase. The effect of chronic feeding with these
types of yeasts during 5,14 and 28 days was investigated
further. Yeast grown on methanol induced a transient
increase of UDP-glucuronyltransferase and γ-glutamyl-
transferase activities. Feeding with yeast grown on
paraffin led to low levels of UDP-glucuronyltransferase
activity similar to that found with casein; repletion with
lactic yeast induced a large enzyme increase in the
specific activity of the enzyme. Lactic yeast which is
very deficient in sulfur amino acids was not supplemented
with methionine. On the basis of the result of the
previous experiment, the role of sulfur amino acids on
the regulation of UDP-glucuronyltransferase activity was
then studied. The rats were fed a balanced diet, the only
variation being in the methionine and cysteine content.
Continuous feeding of the diet deficient in these amino
acids induced a very large increase in the UDP-glucuronyl-
transferase activity (140%) of rat liver microsomes.
Repletion feeding produced an even greater increase.
With continuous feeding of the normal sulfur amino acid
diet, UDP-glucuronyltransferase activity remained stable;
yet on repletion with this diet, the values dropped to
normal. It seems likely that the lack of methionine and
cysteine is related to the high UDP-glucuronyltransferase
activity which may replace the sulfur-conjugation path-
way. Some questions that arose during the discussion
were: Does the latency of the enzyme in the membrane
change? Are higher levels of the transf erase enzyme
produced? Why does gamma-glutamyltransferase
increase? It was also suggested that the activity of the
'sulfur'-requiring conjugation system should be measured.
M. L. Rao (Bonn, F. R. Germany) reported results with
the glucuronic acid conjugating enzyme, found in pig
kidney microsomes. This enzyme conjugates oestrone
selectively at C-3 position. The microsornal preparation
of the pig kidney exhibited the highest specific activity
of the glucuronyltransferase, while containing no j3-
glucuronidase, pyrophosphatase or hydroxylating
activity under the incubation conditions used. The
preparation was then chosen to study the reaction
mechanism in detail. Increasing the concentration of
either substrate (steroid or UDPGA) increased the
affinity of the enzyme for the other substrate. The
slope, n, from the Hill plot, was calculated to be unity
for both oestrone and UDP-glucuroriic acid. The
Koestrone and KUDP.giucoronic acid were 6.6 μπιοΐ/l and
254 μιηοΐ/ΐ, respectively. The oestrone glucuronyltrans-
ferase (UDP-glucuronate: IT/toestradiol 3-glucuronosyl-
transferase, EC 2.4.1.59) of the pig kidney exhibits high
substrate specificity; it is inhibited noncompetitively by
oestradiol-17]8, oestriol, testosterone, phenolphthalein
and bilirubin,p-nitrophenol and 0-aminophenol do not
inhibit the glucuronidation of oestrone. Mg2+ and Ca2"1"
were found to be nonessential activators. The effect of
mercurials suggests the participation of thiol groups in
the enzyme reaction. The enzyme does not exhibit a
phase transition; the maximal activity was observed at
55 °C. One of the two products of the reaction, oestrone
glucuronide, inhibits the enzyme competitively in the
presence of increasing concentrations of UDP-glucuronic
acid. The other product of the reaction, UDP, inhibits
the enzyme noncompetitively with varying UDP-glucu-
ronic acid concentrations. Under incubation conditions
for the glucuronidatipn of oestrone, the enzyme catalyses
the reverse reaction with oestrone glucuronide and UDP
as reactants to the extent of about 0.4% of the forward
reaction; this reverse reaction is also of a sequential
type. In the discussion it was speculated that the pig
kidney oestrone glucuronyltransferase may be a different
enzyme protein.
According to A. B. Graham (Glasgow, Scotland), micro-
somal membrane bound p-nitrophenol UDP-glucuronyl·
transf erase is modulated in two ways by the intact
phospholipid bilayer membrane. Its full activity is
dependent on an intact phospholipid environment, but
it is restricted in activity in microsomal preparations
showing latency by the impermeable nature of the mem-
brane; Since a pure lipid-free glucuronyltransferase
preparation was not available, an attempt was made to
clarify the enzyme's interactions with membrane com-
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ponents, the effect of temperature on the rate of
glucuronidation and the thermotropic structural changes
of membrane phospholipids. Latent enzyme preparations
exhibit biphzsic Arrhenius plots with a reversible dis-
continuity at 20-25 °C (Tc), the activation energy of
glucuronidation (Ea) was higher at T > Tc. When latency
is removed by perturbing the lipid phase of these mem-
branes with phospholipase A, lysophosphatidylcholine,
linoleic acid and Triton X-100, the Arrhenius dis-
continuity is greatly decreased or abolished and Ea
at T > Tc is lowered. Glucuronyltransferase in guinea
pig microsomal membranes prepared and washed with
0.154 mol/1 KC1 is not subject to latency and exhibits
a linear Arrhenius plot from 5 to 40 °C with a high
value of Ea. To obtain further support to these studies
j the polar headgroup area of the lipid bilayer of micro-
I somal membranes and aqueous microsomal phospho-
lipid dispersions was probed with the amphiphilic
fluorophore l-anilino-naphthalene-8-sulphonate; no
phase change was detected between 5 and 35 °C. How-
ever, when N-phenyl-1-naphthylamine was incorporated
into the hydrocarbon core of the bilayer, a transition
centred at 21—25 °C was reported in native microsomal
membranes, in membranes perturbed with phospho-
lipase A and in dispersions of intact and phospholipase-
treated microsomal phospholipids. From these results
it was concluded that membrane permeability is rate-
limiting in microsomal preparations with latent glucu-
ronyltransferase. The Arrhenius discontinuity for glucu-
ronidation in these preparations coincides with a struc-
tural change in the hydrocarbon region of the phospho-
lipid bilayer; that latent glucuronyltransferase is asso-
ciated with a deeply buried lipid domain.
Our knowledge concerning the formation of glucuronides
of steroid hormones in liver diseases is rather confusing.
To obtain detailed information about changes in oestro-
gen metabolism in cirrhotic livers, M Höller (Bonn,
F. R. Germany) studied the influence of cirrhosis on
the uptake, metabolism and biliary secretion of oestrone
and oestradiol-17]3 in the isolated perfused rat liver.
Cirrhosis of the liver was induced by administration of
carbon tetrachloride (i. p. for 10 weeks) and azathioprine
(oral for 10 weeks). Histological examinations of the
livers after chronic treatment with carbon tetrachloride
and azathioprine showed characteristic cirrhotic pattern
in all animals. Twelve weeks later the rats were used for
perfusion of the liver. In some experiments the liver was
post-perfused with an oestrogen^free medium. After
perfusion the liver was homogenised; the homogenate,
the perfusion medium and the bile were worked up
separately and analysed for free and conjugated oestro-
gens. The functioning states of the livers were controlled
by measuring oxygen consumption and oxygen partial
pressure of the liver surface. ATP, ADP, lactate and
pyruvate were determined in the liver; cytochrome
P-450 was measured in the microsomal fraction. Hepatic
clearance rates of oestrone and oestradiol-17/J, the
production rates of different hydroxylated and con-
jugated metabolites and the biliary secretion of the two
oestrogens in normal and cirrhotic livers were compared.
The liver weights were not significantly altered under
the experimental conditions. Compared to untreated
animals, the uptake of oestrone by cirrhotic livers was
diminished. The glucuronide formation of the two
oestrogens, however, appeared to be normal when the
diminished uptake was taken into account. Biliary secre-
tion of oestrone glucuronide was markedly decreased,
whereas a compensatory higher release of the glucuronide
into the perfusate was observed. The decrease in the
uptake of oestrogens could partly be explained by the
formation of circulatory shunts in the cirrhotic liver.
These observations are compatible with the hyper-
oestrogenism observed in human cirrhosis.
G. Brunner (Göttingen, F. R. Germany) reminded the
meeting that in severe liver disease phenolic compounds
are not efficiently glucuronidated, and this results in their
accumulation. These toxic compounds inhibit many
endogenous enzyme systems and affect respiration; they
also probably cause coma. To detoxify the poisons in
the blood of such patients, attempts were made to
replace their defective or deficient UDP-glucuronyl-
transferase. A partially purified UDP-glucuronyltrans-
fer ase (acceptor p-nitrophenol and phenol) was solu-
bilised by detergent treatment and purified 50-fold by
DEAE-cellulose column chiomatography, ammonium
sulfate precipitation and Sephadex G-100 gel filtration.
The solubilised enzyme was covalently bound to a
variety of different carrier materials (e. g. acrylic acid-
acrylamide). The carrier bound enzyme is very stable
and can be used repeatedly for glucuronidation of
phenolic compounds in aqueous solutions as well as in
serum or blood. High concentrations of UDP-glucuronic
acid were needed ibr glucuronidation of toxic substances.
To obviate addition of substrate, UDP-glucuronic acid
can also be entrapped in beads. Effective detoxification
of rabbit blood was demonstrated with this material
in an extracorporeal shunt.
K. W. Bock (Göttingen, F. R. Germany) stated that in-
ducing agents differentially stimulate UDP-glucuronyltrans-
ferases in rat liver. For example, 3-methylcholanthrene
mainly enhances the glucuronidation of 1-naphthol
and 4-nitrophenol, whereas phenobarbital stimulates the
glucuronidation of morphine, chloramphenicol and bili-
rubin. Rats were treated with 3-methylcholanthrene or
phenobarbital; UDP-glucuronyltransferase, using
1-naphthol and morphine as substrates, was separated
and partially purified. The presence of Brij 58 or Lubrol
WX was essential. During the purification substantial
amounts of phospholipids were removed. The molecular
weight of the enzyme (1-naphthol as acceptor) was
found to be about 58000 daltons. 3-Methylcholanthrene
appeared to induce the transferase by de novo protein
synthesis. Experiments with phospholipase suggested
that detergents could replace phospholipids; the enzyme
J. Clin. Chem. Clin. Biochem. / Vol. 18, 1980 / No. 5
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is phospholipid dependent. Comparative studies on the
formation of 1 -naphthol glucuronide in the isolated
perfused rat liver and in liver homogenates or microsomes
indicated that the enzyme operates largely in a con-
strained form intracellularly. This constraint varies
depending upon substrate and species. The constraint
is probably due to a limited access of substrate and/or
conformational changes of the enzyme which alter the
effects of physiological modifiers, such as UDP-N-acetyl-
glucosamine and UDP. The importance of the modifiers
is demonstrated in the course of liver injury caused by
CC14. During acute liver injury the constraint on UDP-
glucuronyltransferase is released, while the level of the
enzyme is decreasing. Release of the constraint leads to
loss of the allosteric activation of the enzyme by
UDP-N-acetylglucosamine, thus counteracting the
activation due to membrane injury. Glucuronide forma-
tion in the perfused liver decreases but less than might
be expected from the severity of liver damage. The
content of UDP-glucuronic acid is not significantly
altered under these conditions. In the discussion it was
pointed out that the Folch extraction to remove phospho-
lipids from membranes is inadequate, especially when
the phospholipids are tightly bound.
G. J. Dutton (Dundee, Scotland) discussed the perinatal
induction of UDP-glucuronyltransferase in chick embryo
and in rat liver. In the chick embryo, transferase activity
(acceptor o-aminophenol) developed 1-5 days after
birth. Premature induction could be brought about by
administration of pituitary extracts, corticotropin or
glucocorticoids. Normal activation appears to occur as a
result of secretion of endogeneous activator 2-3 days
before birth. In the rat, the transferase activity with
o-aminophenol,p-nitrophenol, 1-naphthol, serotonin or
methylumbelliferone as acceptors, develops shortly
before birth; this activity could be induced in cultures
of foetal liver by adding dexamethasone to the medium.
Transferase activity with a second group of substrates,
e. g. bilirubin, oestrone, testosterone, morphine, chlor-
amphenicol and phenolphthalein develops somewhat
later and was not induced by dexamethasone. Thyroxine
had no effect on o-aminophenol glucuronidation. The
results were interpreted as follows: UDP-glucuronyl-
transferase activities toward a range of substrates in the
rat which develop perinatally fall into two main
'clusters': those reaching maximal activity before or at
birth and those reaching it after birth. Activities in the
first cluster are induced by glucocorticoids and those
in the second require different or additional factors.
Various metabolic disorders due to an imbalance of
steroid hormone production or secretion are known in
clinical endocrinology (G. S. Rao, F. R. Germany). The
reasons for over-production of steroid hormones have
been and are subjects of several investigations. The
excretion of the hormones and the role of UDP-glucu-
ronyltransf erases under these conditions has not received
the desired attention. Two questions were asked:
1. Are steroid glucuronyltransferases controlled by their
natural substrate?
2. What are the effects of drugs and carcinogens on the
activity of steroid glucuronyltransferases?
The experimental set-up consisted of studying the effect
of ovariectomy and castration on the activity of the
micrpsomal UDP-glucuronyltransferase, with oestrone
and testosterone as substrates. The animals were then
given oestradiol-17j3 and testosterone and activity was
re-examined. Since it is known that drugs and carcino-
gens, e. g. phenobarbital and 3-methylcholanthrene,
induce UDP-glucuronyltransferase which accepts non-
endogenous compounds as substrates (p-nitrpphenol,
menthol, etc.), the effect of these two.inducers on
steroid glucuronyltransferases were also investigated.
The results suggested that oestrone glucuronyltrans-
ferase is controlled by its substrate and that steroid
glucuronyltransferases are not inducible by pheno-
barbital.
Discussing some recent results on reconstitution of drug
hydroxylation and glucuronidation, O. Hänninen
(Kuopio, Finland) pointed out that oxidation and
glucuronidation reactions take place in sequence,
resulting in the release of the glucuronide. In order to
study the sequence, components of the microsomes
were purified e.g. cytochrome P-450 and UDP-glucu-
ronyltransferase. Starting with phenobarbital-treated
rats, the liver microsomes were treated with deoxy-
cholate, followed by ammonium sulfate fraetionation.
7-Hydroxycoumarin was used as acceptor. Reconstitu-
tion experiments contained cytochrome P-450, the
reductase, the transferase, phospholipid, UDP-glucuronyl-
transferase, phosphate- and Tris buffer, NADP, MgCl2,
7-hydroxycoumarin, haemin and UDP-glucuronic acid.
The deethylation of 7-hydroxycoumarin by the re-
constituted system required phospholipid, but this
appeared to be unsuitable for the transferase. Surfac-
tants could be inhibitory to other enzyme systems and
caution was recommended. When using such reagents
it was stressed that alternative stimulating lipids should
be looked for.
In conclusion, the results presented reflected aspects of
the enzyme which could be of advantage to one or the
other investigator. For the clinical chemist several
presentations certainly were promising and revealed
possibilities for applications in medicine. Intrinsic
properties of the enzyme were highlighted by another
series of lectures. The presentations on purification and
induction of the enzyme showed that new avenues for
the investigator are now open. The need for extensive
communication between those working in this field was
recognised by all participants.
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